大蒜素诱导人胃癌SGC-7901细胞凋亡

该研究探讨了大蒜素诱导人胃癌SGC-7901细胞凋亡及其作用机制。用不同浓度大蒜素作用人胃癌SGC-7901细胞48 h。通过MTT法检测细胞活性。光学、激光共聚焦显微镜下观察细胞形态变化。流式细胞术检测细胞凋亡率和细胞周期。qRT-PCR和Western blot检测Bax、Bcl-2基因和蛋白的表达水平。结果显示,大蒜素处理细胞48 h的IC50值为78μg/m L,显微镜下可观察到明显的凋亡现象,细胞凋亡率为(61.15±3.77)%,细胞阻滞于G1期,Bcl-2基因和蛋白表达均下降,Bax基因和蛋白表达均增加(P0.05)。综上所述,在一定浓度范围内,大蒜素能抑制人胃癌SGC-7901细胞增殖,诱导细胞凋亡,呈剂量依赖性,并可上调Bax基因表达,下调Bcl-2基因表达。     

ErbB-4受体介导卵巢癌细胞增殖、侵袭等生物学行为的实验研究

探讨ErbB- 4受体在卵巢癌细胞增殖、侵袭等生物学行为中的作用.免疫组化检测ErbB- 4受体在卵巢癌细胞株OVCAR-3表达;噻唑蓝比色法(MTT)测定不同浓度的ErbB- 4单克隆抗体(Ab-3)对体外培养的卵巢癌OVCAR-3细胞增殖的影响;流式细胞仪检测细胞周期和凋亡;侵袭实验观察Ab-3对OVCAR-3侵袭能力的影响.结果表明,ErbB- 4在OVCAR-3细胞株中呈阳性表达;不同浓度(0.625～10 μg/ml)的Ab-3均能抑制OVCAR-3细胞生长,且具有浓度和时间依赖性,其作用72 h的中效浓度为4.48 μg/ml.流式细胞仪检测发现Ab-3(2.0 μg/ml)作用24、48及72 h后,OVCAR-3细胞出现S期阻滞,肿瘤细胞的凋亡率逐渐增加;抗体处理组穿透侵袭小室滤膜的细胞数(78.0±6.1)明显少于对照组(132.0±17.2)(P<0.01).因此,Ab-3可抑制内源性ErbB- 4表达的OVCAR-3细胞株的增殖、侵袭能力,诱导细胞凋亡.     

桦褐孔菌提取物对胃癌MGC-803细胞株的抗增殖与诱导凋亡作用

探讨了桦褐孔菌提取物对胃癌MGC - 80 3细胞株的抗增殖、诱导凋亡作用及对凋亡相关基因表达的影响。MTT比色法结果显示 ,桦褐孔菌提取物在 0 .5～ 16 0 μg/mL范围内 (其IC50 为 4 μg/mL)对胃癌MGC- 80 3细胞株均有抑制作用 ,并表现出浓度依赖性关系 ;凋亡形态学观察结果 ,药物浓度 2 μg/mL ,作用时间 12～ 2 4h后 ,细胞核染色质固缩并凝结成块 ,聚集在核膜周边 ,凋亡小体形成 ;TUNEL法检测结果 ,不同浓度药物均诱导胃癌MGC - 80 3细胞株凋亡 ,细胞凋亡率随药物浓度增加而上升 ,显示明显的量效关系。Ki- 6 7抗原检测结果 ,不同浓度药物均抑制胃癌MGC - 80 3细胞株增殖 ,表现出浓度、时间依赖性关系 ;2μg/mL桦褐孔菌提取物作用胃癌MGC - 80 3细胞株 4 8h之后 ,明显下调Bcl - 2基因蛋白表达。因此 ,通过此项研究可得出 ,桦褐孔菌提取物对胃癌MGC - 80 3细胞株有抗增殖作用和诱导凋亡作用 ,其凋亡的分子生物学机制可能与下调凋亡抑制基因Bcl 2表达有一定关系。     

槲皮素对人脑胶质瘤干细胞生物学行为及miR-29s家族的影响分析

目的探讨分析槲皮素对人脑胶质瘤干细胞（BGSCs）生物学行为及miR-29s家族的影响。 方法使用干细胞培养液对U87人脑胶质瘤细胞进行培养,采用CCK-8法检测槲皮素对BGSCs细胞增殖抑制率,采用流式细胞技术检测槲皮素对BGSCs细胞凋亡影响,并采用real-time PCR鉴定槲皮素对BGSCs细胞中miR-29a、miR-29b以及miR- 29c表达的影响。采用t检验以及方差分析进行统计学分析。 结果随着槲皮素浓度的增加,BGSCs细胞增殖抑制率增加24 h 0 μg/ml（0.00±0.12）%、10 μg/ml（1.36±0.38）%、20 μg/ml（15.33±3.01）%、40 μg/ ml（29.50±4.57）%、80 μg/ml（40.21±6.42）%、160 μg/ml（61.21±7.48）,F = 76.273,P < 0.05;48 h 0 μg/ml （0.09±0.05）%、10 μg/ml（9.84±2.17）%、20 μg/ml（28.57±3.84）%、40 μg/ ml（43.59±5.21）%、80 μg/ml（59.50±3.28）%、160 μg/ ml（70.21±9.48）%,F = 85.392,P < 0.05,且同浓度槲皮素作用48 h对BGSCs细胞增殖抑制率高于作用24 h（P < 0.05）。随着槲皮素浓度的升高,BGSCs细胞凋亡率升高[0 μg/ml（13.42±1.21）%、20 μg/ml（38.47±9.28）%、40 μg/ml（59.34±7.20）%、80 μg/ml（71.42±9.47）%,F = 57.493,P < 0.05]。不同浓度槲皮素处理BGSCs细胞后,可促进BGSCs细胞miR-29s家族miR- 29a/ b/ c相对表达量,且随着槲皮素浓度的增加,BGSCs细胞miR-29s家族相对表达量增加[miR-29a 0 μg/ml（1.04±0.08）、20 μg/ml（1.16±0.05）、40 μg/ml（1.30±0.10）、80 μg/ ml（1.41±0.09）,F = 19.281,P < 0.05;miR-29b 0 μg/ml（1.06±0.09）、20 μg/ml（1.13±0.05）、40 μg/ml（1.25±0.07）、80 μg/ml（1.30±0.09）,F = 13.427,P < 0.05;miR-29c 0 μg/ml（1.03±0.07）、20 μg/ml（1.15±0.03）、40 μg/ml（1.22±0.06）、80 μg/ml（1.31±0.08）,F = 14.502,P < 0.05]。 结论槲皮素可有效抑制人脑BGSCs增殖,促进人脑BGSCs凋亡,并促进人脑BGSCs中miR- 29s家族表达。     

唐古特大黄多糖组分1对辐射损伤所致肠上皮细胞凋亡的保护作用及其可能的机制

目的:探讨唐古特大黄多糖(Rheum tanguticum polysaceharide,RTP)组分1(RTP1)对60yCo射线诱导的肠上皮细胞IEC-6凋亡的保护作用及其可能的机制.方法:采用大鼠空肠上皮细胞(IEC-6细胞株),共分为4组,正常对照组(Normal Control,NC)、辐射对照组(Irradiation Control,Ic)以及RTP1低剂量组(10 μg/m1)、中剂量组(30 μg/m1)和高剂量组(100 μg/ml),以6.0 Gy60Coγ射线一次性照射损伤细胞,损伤前用RTP1预处理细胞48 h.采用MTT比色法测定细胞活力,吖啶橙荧光染色及流式细胞仪检测细胞凋亡的发生,Western blot测定Caspase-3酶活性.结果:6.0 Gy60Coγ射线照射可明显降低细胞存活率并诱导细胞凋亡,凋亡率为31.3％,细胞Caspase-3的活性明显升高,RTP1预处理细胞可明显提高细胞存活率,流式细胞仪检测凋亡率(30、100μg/ml)分别降低至24.4％和21.5％,Caspase-3酶活性降低,并呈现一定的剂量依赖性.结论:RTP1可明显抑制60γCo射线诱导的IEC-6细胞凋亡,其细胞保护作用可能与抑制Caspase-3活性相关.     

大蒜素诱导结肠癌HT-29细胞凋亡

本实验的目的是观察大蒜素(allicin)对人结肠癌HT-29细胞凋亡和增殖的影响,并对其作用机制做初步的探讨。通过利用倒置显微镜、荧光显微镜、透射电镜、流式细胞术以及Real time PCR等方法,对大蒜素处理后的HT-29细胞的形态、存活率、细胞周期分布、细胞凋亡率、线粒体膜电位(驻追m)以及Bax/Bcl-2基因表达比例的变化进行了研究。结果显示,大蒜素可抑制HT-29细胞增殖,且呈剂量依赖性关系。大蒜素作用于HT-29细胞48 h的最佳药物浓度是6滋g/m L。在此条件下,细胞出现明显的凋亡现象。早期和晚期细胞凋亡率分别为(7.48依0.38)%和(10.07依0.78)%,驻追m显著下降(p0.01),细胞被阻滞于S期和G2期,Bax/Bcl-2的比值显著升高(p0.01)。因此,我们推测大蒜素可能通过调节Bax和Bcl-2两个基因的表达比例,诱导人结肠癌HT-29细胞的凋亡,进而抑制癌细胞的增殖。     

盐酸罗哌卡因对骨肉瘤细胞增殖、侵袭、凋亡的影响及其机制*

目的:探讨盐酸罗哌卡因对骨肉瘤细胞增殖、侵袭、凋亡的影响及分子机制。方法:采用逐步增加药物剂量诱导法建立骨肉瘤多柔比星耐药细胞株(U2OS/DOX),用浓度分别为0、20、50、100 μg/ml的盐酸罗哌卡因处理U2OS/DOX细胞,作为不同浓度盐酸罗哌卡因处理组;将pcDNA3.1、pcDNA3.1-Livin转染至U2OS/DOX细胞中再用浓度为100 μg/ml的盐酸罗哌卡因处理,记为盐酸罗哌卡因100 μg/ml+pcDNA3.1组、盐酸罗哌卡因100 μg/ml+pcDNA3.1-Livin组。MTT检测细胞增殖抑制率及细胞半数抑制浓度(IC₅₀);蛋白质印迹(Western blot)法检测细胞周期蛋白依赖性激酶抑制剂1A(P21)、活化的半胱氨酸天冬氨酸蛋白酶-3(Cleaved Caspase-3)、上皮钙黏蛋白(E-cadherin)、基质金属蛋白酶2(MMP-2)、Livin蛋白表达;克隆形成实验检测细胞克隆形成数;流式细胞术检测细胞凋亡;Transwell检测细胞迁移和侵袭;实时荧光定量PCR(RT-qPCR)检测Livin mRNA表达水平。结果:多柔比星浓度大于1 μg/ml时,骨肉瘤细胞U2OS增殖抑制率显著升高,且具有剂量依赖性(P＜0.05);多柔比星浓度大于10 μg/ml时,骨肉瘤细胞骨肉瘤耐药细胞U2OS/DOX增殖抑制率显著升高,且具有剂量依赖性(P＜0.05)。盐酸罗哌卡因处理的U2OS/DOX细胞中P21、Caspase-3、E-cadherin表达水平显著升高,MMP-2表达水平显著降低,细胞增殖抑制率显著升高,克隆形成数显著降低,细胞凋亡率显著升高,细胞迁移、侵袭数显著降低,Livin表达水平显著降低,且呈浓度依赖性(P＜0.05)。过表达Livin部分逆转了盐酸罗哌卡因对细胞U2OS/DOX增殖、迁移、侵袭的抑制作用及凋亡的促进作用。结论:盐酸罗哌卡因能明显抑制对多柔比星具有耐药性的骨肉瘤细胞的增殖,迁移和侵袭,明显促进骨瘤细胞凋亡,其机制可能与Livin有关。     

槲皮素对UVB辐射HaCaT细胞膜流动性的影响

目的:基于过量UVB照射角质形成细胞HaCaT所致细胞膜流动性变化,探讨植物单体槲皮素(Qu)对细胞光应激的保护机制.方法:体外培养HaCaT细胞,分别加入25μg/mL、50 μg/mL、100 μg/mL的Qu,孵育后更换培养基,以30mJ/cm2 UVB剂量进行照射,Dio荧光探针标记细胞膜,激光共聚焦显微镜下观察其膜流动性的变化.结果:紫外照射组细胞膜流动性扩散系数D及荧光恢复率R最低;50μg/ml药物组荧光恢复率明显优于25μg/mL药物组,100 μg/mL药物组略优于50 μg/mL药物组,与正常组无显著性差异.结论:一定浓度范围内Qu对UVB所致的细胞膜的流动性损伤具有明显的保护作用(P＜0.05),并与剂量成正相关性.     

霉酚酸酯对人肝癌细胞HepG-2抑制作用的研究

目的:研究霉酚酸酯体外对细胞生长抑制率、细胞凋亡以及对细胞黏附率的影响.方法:以霉酚酸酯在0.1μg/ml-100μg/ml,24-72h内作用于肝癌细胞,MTT法检测肿瘤细胞的生长抑制率,流式细胞仪检测细胞周期,Hoeehst33258荧光染色观察细胞凋亡的形态变化,细胞黏附实验检测细胞黏附率的影响.结果:霉酚酸酯显著的抑制了肿瘤细胞的增长,并显著的抑制其黏附率,在浓度为100μg/ml作用72小时时生长抑制率达78.8%,黏附率降低至42.1%,Hoechst33258染色实验发现随浓度增大细胞凋亡的发生增多,核固缩、核碎裂的现象发生越明显.流式细胞仪检测,细胞周期阻滞于GO/G1期,减少增殖细胞在S期的分布.结论:霉酚酸酯对肝癌细胞HepG-2的增长具有明显的抑制作用.     

纳米ZnO对人肺上皮细胞BEAS-2B细胞增殖和凋亡的影响

目的:探讨纳米ZnO对人肺上皮细胞BEAS-2B细胞增殖、凋亡的影响及分子机制。方法:用终浓度为3、6、12μg/ml的纳米ZnO处理BEAS-2B细胞12 h和24 h,对照组未加入纳米ZnO,各设3复孔,CCK-8法检测细胞活力,分析半致死浓度。筛选3、6μg/ml纳米ZnO处理BEAS-2B细胞24 h,各设3复孔,倒置显微镜观察细胞形态,Hochest33342染色观察细胞核,AO染色及扫描电镜观察细胞凋亡形态,流式细胞术检测活性氧水平、细胞周期进程、细胞凋亡;Western blot检测Bcl-2、Bax蛋白表达水平。结果:与对照组相比,纳米ZnO处理组细胞活力显著下降(P<0.01),处理24 h时IC₅₀为6.13μg/ml;纳米ZnO处理细胞24 h后,3μg/ml和6μg/ml组的活性氧水平显著升高(P<0.05,P<0.01)。6μg/ml处理组细胞周期阻滞于G2/M期、染色质固缩凝集、出现凋亡小体、细胞凋亡率显著增加(P<0.01)、Bcl-2蛋白表达显著降低(P<0.05)、Bax蛋白表达显著升高(P<0...     

Stimulative effects of insulin on Toxoplasma gondii replication in 3T3-L1 cells

The influence of insulin and 2-deoxy-glucose (D-glucose) on the intracellular protozoan Toxoplasma gondii replication in 3T3-L1 cells was investigated. Insulin and D-glucose had a dose-responsive mitogenic effect on intracellular T. gondii replication and development in 3T3-L1 cells. Insulin concentrations between 10(-2) and 10(-1) microg/ml combination of 4.5 g/l D-glucose in DMEM medium gave maximum stimulus to T. gondii replication. The number of tachyzoites increased rapidly, with the growth peaking typically on day 3 or 4 of culture, and then declining quickly. However, insulin, in the absence of d-glucose, had comparably less effect on T. gondii growth than two of their combination. d-glucose concentrations significantly affected the tachyzoite replication and appear to be indispensable for maintaining the host 3T3-L1 cells.     

Pyridinylimidazole p38 mitogen-activated protein kinase inhibitors block intracellular Toxoplasma gondii replication

Toxoplasma gondii is a medically important, obligate intracellular parasite. Little is known regarding factors that regulate its replication within cells. Such knowledge would further understanding of T. gondii pathogenesis, and might lead to novel therapeutic strategies. Mitogen-activated protein kinases (MAPKs) govern diverse cellular processes including proliferation and differentiation. We now show that treatment of T. gondii-infected cells with SB203580 or SB202190, substituted pyridinylimidazoles that are potent inhibitors of human p38 MAPK, inhibits intracellular T. gondii replication. Several independent experimental approaches suggest that the anti-proliferative effects of pyridinylimidazoles depend on direct action on tachyzoites, not the host cell: (i) selective inhibition of host p38 MAPK using recombinant adenoviruses had little effect on tachyzoite replication, (ii) pyridinylimidazole-treated tachyzoites developed abnormal morphology suggesting defective parasite division, and (iii) pyridinylimidazole-resistant mutant tachyzoites were developed through culture in progressively higher drug concentrations. We hypothesise that pyridinylimidazoles target a human p38 MAPK homologue in tachyzoites that regulates their replication. Phylogenetic data suggest that T. gondii likely encodes a p38 MAPK homologue, but such a homologue is absent from the incomplete Toxoplasma genomic data base. As all eukaryotic pathogens, including agents of malaria, leishmaniasis and trypanosomiasis encode endogenous MAPKs, drugs inhibiting endogenous MAPK activation may represent a novel, potentially broadly-acting class of anti-parasitic agents. Pyridinylimidazoles also represent tools to elucidate factors governing intracellular tachyzoite replication.     

Involvement of the mitogen-activated protein (MAP) kinase signalling pathway in host cell invasion by Toxoplasma gondii

Little is known about signalling in Toxoplasma gondii, but it is likely that protein kinases might play a key role in the parasite proliferation, differentiation and probably invasion. We previously characterized Mitogen-Activated Protein (MAP) kinases in T. gondii lysates. In this study, cultured cells were tested for their susceptibility to Toxoplasma gondii infection after tachyzoite pretreatment with drugs interfering with MAP kinase activation pathways. Protein kinases inhibitors, i.e. genistein, RO31-8220 and PD098059, reduced tachyzoite infectivity by 38 +/- 4.5%, 85.5 +/- 9% and 56 +/- 10%, respectively. Conversely, protein kinases activators, i.e. bombesin and PMA, markedly increased infectivity (by 202 +/- 37% and 258 +/- 14%, respectively). These results suggest that signalling pathways involving PKC and MAP kinases play a role in host cell invasion by Toxoplasma.     

Evaluation of PCR methods for 5S-rDNA and p30 genes to detect Toxoplasma gondii in blood and other clinical samples

During the last few years the direct diagnosis of Toxoplasma gondii infection has taken advantage of PCR. The present work tested the sensitivity and specificity of PCR for rDNA and p30 genes. Using ascitic fluid from infected mice rDNA PCR detected 0.5 tachyzoite/ml, while nested p30 PCR 1 tachyzoite/ml. The rDNA amplification was positive in all clinical samples from a single immuno compromised patient (blood, urine and bronchoalveolar fluid). In the same patient nested p30 PCR was positive only in urine and bronchoalveolar lavage (BAL) fluid. The rDNA and p30 amplicons were never found in any amniotic fluids tested. These results could prove the usefulness of rDNA amplification to detect T. gondii in blood.     

淫羊藿苷促进宫颈癌TC-1细胞凋亡作用的研究

目的：研究淫羊藿苷体外对致宫颈癌TC-1细胞的增殖抑制及促凋亡作用。方法：利用细胞培养,用不同浓度的淫羊藿苷在一定的时间处理致宫颈癌TC-1细胞,光学显微镜直接观察药物对细胞的作用;MTT法检测淫羊藿苷对TC-1细胞的增殖抑制作用;Dapi核染色、Annexinv-FITC/PI流式细胞学检测细胞凋亡。结果：淫羊藿苷对TC-1细胞有显著的抑制作用,且呈时间、剂量依赖,20μg/ml作用72小时后,细胞抑制率达99%;DAPI核染色和流式细胞术检测可发现典型细胞凋亡特征。结论：淫羊藿苷对TC-1细胞增殖有抑制和促凋亡作用,并呈时间浓度依赖性。     

康莱特联合顺铂对宫颈癌SiHa细胞增殖和凋亡的影响

目的:通过康莱特联合顺铂对宫颈癌SiHa细胞增殖和凋亡的影响,探讨其作用机制。方法:体外培养宫颈癌Siha细胞,分别将康莱特(浓度为1,2,4,6,8 mg/mL),顺铂(浓度梯度为1.5,3,6,9,12μg/mL),单独作用于宫颈癌SiHa细胞,加药24h、48h用噻唑蓝(MTT法)检测细胞增殖情况。用流式细胞术检测康莱特组和顺铂组细胞24h凋亡率,选取合适的药物浓度(康莱特6 mg/mL,顺铂3μg/mL),进行联合用药,加药24h、48h用MTT法检测细胞增殖情况,用流式细胞术检测24h细胞凋亡率。结果:①MTT法显示加药后两组的24h、48h,宫颈癌SiHa细胞的抑制率均高于对照组(P0.05),并且在一定程度上呈浓度和时间依赖性。②联合用药时,细胞的抑制率和凋亡率要显著高于单独用药(P0.01)。结论:康莱特、顺铂单独或联合作用均能抑制SiHa细胞的增殖,促进其凋亡,且康莱特联合顺铂的作用要显著高于单独用药,康莱特与化疗药物联合使用可提高肿瘤细胞对化疗药物的敏感性。     

Vertical toxoplasmosis in a murine model. Protection after immunization with antigens of Toxoplasma gondii incorporated into liposomes

Distinct Toxoplasma gondii antigens were entrapped within liposomes and evaluated for their ability to protect Balb/c mice against congenital transmission: soluble tachyzoite antigen (L/STAg), soluble tissue cyst antigen (L/SCAg), soluble tachyzoite plus tissue cyst (L/STCAg) or purified 32kDa antigen of tachyzoite (L/pTAg). Soluble tachyzoite antigen alone in PBS (STAg) or emulsified in Freund's Complete Adjuvant (FCA/STAg) was also evaluated. Dams were inoculated subcutaneously with these antigens 6, 4 and 2 weeks prior to a challenge with four tissue cysts of the P strain of T. gondii orally between 10 and 14 days of pregnancy. Significant diminution differences were observed between the frequency of infected pups born of the dams immunized with the antigens incorporated into liposomes and that of pups born of the dams immunized with antigen emulsified in FCA or non immunized group (p<0.05). There was a significant decrease in the number of pups born dead in the groups L/STAg, L/SCAg and L/pTAg when compared with pups from all other groups (p <0.05). All dams immunized with or without adjuvant showed an antibody response and a proliferation of T-cells. However, no correlation was found between immune response and protection against the challenge.     

A new alternative in vitro method for quantification of Toxoplasma gondii infectivity

An in vitro method to determine the infectious potency of an unknown suspension of the protozoan parasite Toxoplasma gondii based on kinetics of host cells lysis was developed. Mic1-3KO a mutant strain of T. gondii RH tachyzoites was inoculated in 25-cm2 flasks containing a 90% confluent monolayer of human foreskin fibroblasts. Lysis kinetics was monitored for infection ratios ranging from 1∶10? to 1∶10; we defined 10? tachyzoites/ml?1 as the threshold value for parasite egress. Results allowed us to build a calibration curve relating the initial infection ratios to the time needed to reach 10? tachyzoites/ml?1. Finally, we validated the method using a known mixture of dead and live parasites. This method was found to estimate with accuracy the initial ratio of infection of the unknown parasite suspension. This easy-to-use method is reproducible and can be applied to any T. gondii tachyzoite RH strain, genetically modified or not. This method is also suitable for testing promising candidates for an effective live vaccine.